News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
331,208 Results
Type
Article (27039)
Company Profile (149)
Press Release (304020)
Multimedia
Podcasts (32)
Webinars (11)
Section
Business (92737)
Career Advice (1322)
Deals (14409)
Drug Delivery (83)
Drug Development (38757)
Employer Resources (155)
FDA (8258)
Job Trends (8680)
News (155843)
Policy (13772)
Tag
Academia (2003)
Academic (2)
Accelerated approval (3)
Adcomms (17)
Allergies (76)
Alliances (25594)
ALS (71)
Alzheimer's disease (872)
Antibody-drug conjugate (ADC) (80)
Approvals (8291)
Artificial intelligence (188)
Autoimmune disease (14)
Automation (13)
Bankruptcy (102)
Best Places to Work (7418)
BIOSECURE Act (13)
Biosimilars (72)
Biotechnology (93)
Bladder cancer (57)
Brain cancer (17)
Breast cancer (168)
Cancer (1256)
Cardiovascular disease (112)
Career advice (1167)
Career pathing (33)
CAR-T (91)
Cell therapy (262)
Cervical cancer (14)
Clinical research (31576)
Collaboration (564)
Compensation (215)
Complete response letters (12)
COVID-19 (1419)
CRISPR (31)
C-suite (183)
Cystic fibrosis (91)
Data (1489)
Decentralized trials (1)
Denatured (21)
Depression (29)
Diabetes (168)
Diagnostics (3417)
Digital health (7)
Diversity (7)
Diversity, equity & inclusion (39)
Drug discovery (75)
Drug pricing (62)
Drug shortages (6)
Duchenne muscular dystrophy (65)
Earnings (27396)
Editorial (22)
Employer branding (24)
Employer resources (134)
Events (49994)
Executive appointments (540)
FDA (9164)
Friedreich's ataxia (2)
Frontotemporal dementia (4)
Funding (532)
Gene editing (73)
Generative AI (18)
Gene therapy (223)
GLP-1 (409)
Government (2362)
Grass and pollen (2)
Guidances (85)
Healthcare (10049)
Huntington's disease (16)
IgA nephropathy (21)
Immunology and inflammation (60)
Indications (17)
Infectious disease (1507)
Inflammatory bowel disease (110)
Inflation Reduction Act (8)
Influenza (27)
Intellectual property (53)
Interviews (199)
IPO (6485)
IRA (24)
Job creations (1603)
Job search strategy (1016)
Kidney cancer (2)
Labor market (39)
Layoffs (203)
Leadership (16)
Legal (2242)
Liver cancer (43)
Lung cancer (171)
Lymphoma (96)
Machine learning (4)
Management (52)
Manufacturing (198)
MASH (34)
Medical device (6550)
Medtech (6554)
Mergers & acquisitions (8298)
Metabolic disorders (399)
Multiple sclerosis (53)
NASH (12)
Neurodegenerative disease (48)
Neuropsychiatric disorders (8)
Neuroscience (1246)
NextGen: Class of 2025 (3748)
Non-profit (3467)
Now hiring (39)
Obesity (199)
Opinion (139)
Ovarian cancer (47)
Pain (59)
Pancreatic cancer (44)
Parkinson's disease (106)
Partnered (18)
Patents (117)
Patient recruitment (71)
Peanut (42)
People (33969)
Pharmaceutical (41)
Pharmacy benefit managers (5)
Phase I (9124)
Phase II (13635)
Phase III (11683)
Pipeline (782)
Policy (74)
Postmarket research (1246)
Preclinical (4035)
Press Release (61)
Prostate cancer (65)
Psychedelics (18)
Radiopharmaceuticals (126)
Rare diseases (292)
Real estate (3233)
Recruiting (59)
Regulatory (10383)
Reports (42)
Research institute (1747)
Resumes & cover letters (169)
Rett syndrome (6)
RNA editing (2)
RSV (32)
Schizophrenia (49)
Series A (98)
Series B (61)
Service/supplier (8)
Sickle cell disease (40)
Special edition (9)
Spinal muscular atrophy (109)
Sponsored (24)
Startups (2387)
State (1)
Stomach cancer (9)
Supply chain (34)
Tariffs (15)
The Weekly (11)
Vaccines (339)
Venture capitalists (34)
Weight loss (124)
Women's health (16)
Worklife (18)
Date
Today (67)
Last 7 days (565)
Last 30 days (1878)
Last 365 days (18864)
2025 (7038)
2024 (20388)
2023 (22766)
2022 (28074)
2021 (31157)
2020 (28800)
2019 (25558)
2018 (19024)
2017 (16616)
2016 (16122)
2015 (17745)
2014 (12883)
2013 (10439)
2012 (10969)
2011 (11340)
2010 (10218)
Location
Africa (491)
Alabama (30)
Alaska (7)
Arizona (111)
Arkansas (9)
Asia (19060)
Australia (3435)
California (3616)
Canada (1069)
China (256)
Colorado (139)
Connecticut (177)
Delaware (122)
Europe (47323)
Florida (573)
Georgia (143)
Hawaii (1)
Idaho (23)
Illinois (286)
India (22)
Indiana (265)
Iowa (8)
Japan (139)
Kansas (47)
Kentucky (15)
Louisiana (9)
Maine (14)
Maryland (472)
Massachusetts (2769)
Michigan (151)
Minnesota (215)
Mississippi (2)
Missouri (49)
Montana (17)
Nebraska (10)
Nevada (43)
New Hampshire (18)
New Jersey (1144)
New Mexico (19)
New York (1072)
North Carolina (653)
North Dakota (8)
Northern California (1630)
Ohio (134)
Oklahoma (7)
Oregon (23)
Pennsylvania (767)
Puerto Rico (9)
Rhode Island (16)
South America (635)
South Carolina (10)
Southern California (1304)
Tennessee (43)
Texas (473)
United States (13719)
Utah (91)
Virginia (75)
Washington D.C. (43)
Washington State (240)
West Virginia (1)
Wisconsin (50)
331,208 Results for "wave life sciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Wave Life Sciences Reports First Quarter 2025 Financial Results and Provides Business Update
May 8, 2025
·
19 min read
Press Releases
Wave Life Sciences First Quarter 2025 Financial Results Scheduled for May 8, 2025
May 1, 2025
·
1 min read
Press Releases
Sofinnova Partners Raises €1.2 Billion to Fuel the Next Wave of Life Sciences Innovation
March 4, 2025
·
3 min read
Duchenne muscular dystrophy
Wave’s Duchenne Exon-Skipper Reverses Muscle Damage in Mid-Stage Trial
WVE-N531, an oligonucleotide, elicited significant functional benefit and reversal of muscle damage in the Phase II FORWARD-53 trial. Wave plans to file for accelerated approval of the candidate in 2026.
March 26, 2025
·
3 min read
·
Heather McKenzie
Press Releases
Wave Life Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
March 5, 2025
·
17 min read
Press Releases
Wave Life Sciences Fourth Quarter and Full Year 2024 Financial Results Scheduled for March 4, 2025
February 25, 2025
·
1 min read
Press Releases
Wave Life Sciences Announces Initiation of Phase 1 INLIGHT Clinical Trial of WVE-007 in Obesity
February 6, 2025
·
5 min read
Business
New Jersey’s Life Sciences Scene Continues Expanding Beyond Big Pharma
Known as the home of big-name companies including Johnson & Johnson, New Jersey has become a destination for more and more small and midsize life sciences businesses. Choose New Jersey, Grace Therapeutics and Onyx Equities executives discuss the state’s life sciences scene.
April 10, 2025
·
6 min read
·
Angela Gabriel
Press Releases
Wave Life Sciences to Present at Upcoming Investor Conferences
November 26, 2024
·
1 min read
Job Trends
Report: 2025 U.S. Life Sciences Salary Report
March 25, 2025
·
1 min read
·
BioSpace Insights
1 of 33,121
Next
